Research to Revenue Small biotech focused on phage engineering and collaboration with leading universities, presenting a potential upsell path for contract research services, lab automation tooling, or specialized analytics once they scale.

Funding Momentum Recent and notable funding activity including NIH and NSF grants, plus a post-Series B expansion into complex care categories, signaling readiness to adopt scalable service platforms, data management, and commercialization support.

Growth Readiness Current headcount under 10 and revenue under 1M, with strategic investments in warehousing and fulfillment capacity, indicating opportunities for logistics, regulatory compliance, and CRO/CMO partnerships as they expand operations.

Tech Footprint Tech stack features analytics and web infrastructure tools; potential for engagement around data analytics, digital marketing optimization, cloud-based collaboration, and secure data handling as they scale research programs.

Strategic Partnerships Active collaborations with Yale, UC Berkeley, and AnimalBiome point to a pattern of academic and biotech partnerships; ideal target for partnership management platforms, grant consulting, and joint development programs.